As a trusted provider of early-phase clinical trial services, CRS is committed to advancing cardiometabolic research that meets today’s challenges and accelerates the therapies of tomorrow.

With over 45 years of experience in running Phase I-II trials across multiple therapeutic areas, CRS offers comprehensive clinical research services that support the rapid development of new medicines. Our expertise includes managing early-phase clinical trials from First-in-Human to Proof-of-Concept, ensuring high-quality results that adhere to the highest standards of safety and regulatory compliance.

A key highlight of our work includes our collaboration with leading pharmaceutical companies, providing seamless services from study design through to data analysis. Our ability to conduct complex studies in challenging therapeutic areas has been instrumental in the successful development of novel treatments.

CRS operates world-class clinical trial facilities and maintains a network of specialized labs and hospitals to support a wide range of clinical research needs. Our integrated approach, which includes Pre-/Non-Clinical consultancy services at Venn Life Sciences, ensures that studies are executed with the highest level of scientific rigor, regulatory compliance, and operational efficiency.